Search
Showing results for "1"
Research
Lower anti-echovirus antibody responses in children presenting to hospital with asthma exacerbations.This article assesses the absolute and specific antibody titres to VP1 antigens of the gut-trophic enteroviruses, echovirus 30 and Sabin 1 poliovirus, in...
Research
School absence and its effect on school performance for children born with orofacial cleftsWe aimed to describe school absence and its relationship with school performance for children with and without orofacial clefts.
News & Events
Know what you are covered forRecent changes to private health insurance policies are a timely reminder to check your level of cover, especially for those undergoing pump therapy.
News & Events
Congrats Dr Sabrina BinkowskiCongratulations to Dr Sabrina Binkowski from Rio Tinto Children's Diabetes Centre, who was awarded the ANZSPED research grant award of $20,000, at
News & Events
Dexcom G6 Early Access Program UpdateThe Dexcom G6 Early Access Program has so far been a huge success. The program commenced in May, and offered early access to the Dexcom G6 system to eligible patients.
News & Events
Do you have the power?Volunteers are needed for the upcoming camp for 11 and 12-year-olds living with Type 1 Diabetes.
News & Events
Smartphone donationsThe Diabetes Research Team is requesting donations of old iPhones for a new study investigating the effect of real time CGM on every day diabetes management.
News & Events
Low Carbohydrate DietsCarbohydrate restriction is used by some individuals with type 1 diabetes to reduce glucose excursions after eating a meal.
Research
Who suffered most? Parental stress and mental health during the COVID-19 pandemic in GermanyThis study examines gender and socioeconomic inequalities in parental psychological wellbeing (parenting stress and psychological distress) during the COVID-19 pandemic in Germany. Background: The dramatic shift of childcare and schooling responsibility from formal institutions to private households during the pandemic has put families under enormous stress and raised concerns about caregivers’ health and wellbeing.
Research
Early Peanut Immunotherapy in Children (EPIC) trial: Protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of ageFood allergy is a major public health challenge in Australia. Despite widespread uptake of infant feeding and allergy prevention guidelines the incidence of peanut allergy in infants has not fallen, and prevalence of peanut allergy in school-aged children continues to rise. Therefore, effective and accessible treatments for peanut allergy are required.